Clinical Observation of Renal Function Reactivation Following a GRAS-Based Protocol in Patients With Chronic Kidney Disease and Long-Term Renal Arrest.

COMPLETED

NCT07555327

Sponsor: Amar h Zireg

Summary

This observational study documents the impact of a specific oral protocol (based on FDA-GRAS ingredients) on patients with Stage 5 Chronic Kidney Disease (CKD). The study observes 8 participants, including 6 with residual renal function and 2 patients with long-term total renal arrest (16 years and 22 years of anuria). The primary focus is monitoring the restoration of urine output and changes in renal biological markers.

Key Details

Gender

MALE

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

8

Start Date

2026-02-02

Completion Date

2026-05-19

Last Updated

2026-05-27

Healthy Volunteers

Not specified

Conditions

End-Stage Renal Disease (ESRD) Chronic Kidney Disease, Stage 5 Renal Regeneration Anuria Diabetic Nephropathy Anuria End-Stage Renal Disease (ESRD)Chronic Kidney Disease, Stage 5 Renal Regeneration Diabetes Diabetes Complications Non Diabetic Patients Diabetes Mellitus ( Type 1 and Type 2)

Interventions

DIETARY_SUPPLEMENT

CSR-CKD Oral Protocol

A specific oral nutritional intervention consisting of synergistic FDA-GRAS (Generally Recognized As Safe) components designed to support renal tissue recovery and restoration of urine output.

Locations (1)

Amar hocine Zireg

Bordj Bou Arreridj, Wilaya de Bordj Bou Arréridj, Algeria

Clinical Research Directory